BioSpace News Archive

Pharm Country

STRATA Skin Sciences Sponsors Webinars Featuring Leading Dermatologists Discussing Benefits of XTRAC® and TheraClear®X Devices

STRATA Skin Sciences, Inc. announces the availability of two virtual webinars that discuss the benefits of using its XTRAC® excimer device for the treatment of psoriasis, vitiligo, and eczema and its TheraClear®X photopneumatic device for the treatment of mild to moderate acne.

June 12, 2024
·
5 min read
Business

Triveni Bio Appoints Bhaskar Srivastava, M.D., Ph.D., as Chief Medical Officer, Announces Key Program Updates

Triveni Bio Inc. announced that Bhaskar Srivastava, M.D., Ph.D., has joined the company as Chief Medical Officer.

June 12, 2024
·
2 min read
Biotech Beach

Equillium to be included in the Russell Microcap® Index - June 12, 2024

Equillium, Inc. announced that it expects to join the Russell Microcap Index at the conclusion of the 2024 Russell annual reconstitution, effective at the open of equity markets on Monday, July 1, according to a preliminary list of additions posted Friday, May 24.

June 12, 2024
·
5 min read
Pharm Country

DiamiR Announces Oral Presentation on Recent Advances of Its microRNA Biomarker Platform at 2024 International Rett Syndrome Foundation Scientific Meeting

DiamiR Biosciences announced that the company’s co-founder Dr. Kira Sheinerman will present at the 2024 International Rett Syndrome Foundation Rett Syndrome Scientific Meeting, taking place June 18-19, 2024, in Westminster, CO.

June 12, 2024
·
1 min read
Immorta Bio Reports Successful Inhibition of Lung Cancer Growth by Senolytic Immunotherapy Product SenoVax™

Immorta Bio Inc, a science-based Life Extension company announced today positive preclinical findings utilizing its senescent cell-killing immunotherapeutic product SenoVax™ in a model of non-small cell lung cancer.

June 12, 2024
·
3 min read
Drug Development

Ensem Therapeutics Announces Achievement of Milestone Following Entry of Small Molecule CDK2 Inhibitor into Clinical Trials for Solid Tumors

Ensem Therapeutics, Inc. today announced that its partner BeiGene has dosed the first five patients in its first-in-human Phase 1 trial to evaluate BG-68501, a small molecule cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of solid tumors.

June 12, 2024
·
2 min read
SAIL Fusion Announces the U.S. Commercial Launch of its BowTie™ Sacroiliac Fusion System

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced the U.S. commercial launch of its novel BowTie Sacroiliac Fusion System.

June 12, 2024
·
3 min read
Positive Data from IceCure’s Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function

IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”) today announced that data from an interim analysis of its ICESECRET kidney cancer trial were presented at the 3rd Annual Israeli Conference on Interventional Radiology in Tel Aviv, Israel on June 10, 2024.

June 12, 2024
·
5 min read
Genetown

New Thermo Scientific Heracell Incubators Support the Future of Fully Automated Labs

To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo Scientific™ Heracell™ VIOS™ 250i AxD CO2 Incubators.

June 12, 2024
·
3 min read
BioMidwest

Prevounce Health Launches New Cellular-Connected Blood Glucose Meter for Remote Patient Monitoring

Prevounce Health, a leading provider of remote care management software, devices, and services, announces the launch of its first remote blood glucose monitoring device: Pylo GL1-LTE.

June 12, 2024
·
2 min read